Glenmark Pharmaceuticals Inc , US, has been granted final approval by the United States Food & Drug Administration for Adapalene and Benzoyl Peroxide Gel. According to IQVIATM sales data for the 12-month period ended September 2019, the Epiduo Gel (generic version of Glenmark's drug), achieved an annual sales of approximately $33.7 million. Glenmark's current portfolio consists of 163 products authorised for distribution in the US marketplace and 45 ANDA's pending approval with the USFDA. Shares of Glenmark Pharma gained 1.48 per cent to close at ₹290.82 on BSE.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.